PolyPeptide Group AG (PPGN)
SIX
Real-time Data
07:00 AM
Day's Range
44.0552 wk Range
21.80Overview - PPGN - PolyPeptide Group AG
Key Statistics
Valuation
Enterprise Value
1.45B
P/E (Trailing)
‪105.11‬
P/E (Forward)
‪30.41‬
PEG Ratio
‪30.41‬
Price / Sales (TTM)
‪3.17‬
Price / Book
‪4.38‬
EV / EBITDA
‪20.53‬
Profitability
Profit Margin
‪3.14%‬
Operating Margin
‪9.28%‬
Return on Assets
‪3.37%‬
Return on Equity
‪4.23%‬
Ownership
Shares Outstanding
33.01M
Float
12.96M
Held by Insiders
‪60.52%‬
Held by Institutions
‪13.83%‬
Price stats
Beta
‪1.00‬
50-Day Avg
‪43.94‬
200-Day Avg
‪35.19‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
5 analysts
Average price target
‪CHF 39.86‬Market Cap - PPGN - PolyPeptide Group AG
Peers - PPGN - PolyPeptide Group AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on SIX.
Profile Summary - PPGN - PolyPeptide Group AG
About
PolyPeptide Group AG is a specialized Contract Development & Manufacturing Organization (CDMO) focused on peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). Established with roots dating back to 1952 in Malmö, Sweden, it supports pharmaceutical and biotech companies by providing comprehensive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
